fluorodeoxyglucose f18 has been researched along with Spinal Cord Diseases in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (30.00) | 29.6817 |
2010's | 12 (60.00) | 24.3611 |
2020's | 2 (10.00) | 2.80 |
Authors | Studies |
---|---|
Gule-Monroe, MK; Johnson, JM; Ordóñez-Rubiano, EG; Row, W; Solano-Noguera, DF; Tatsui, CE; Weinberg, J | 1 |
Dhanapalaratnam, R; Huynh, W | 1 |
Bai, Y; Dong, A; Liu, M; Liu, Q; Lu, L | 1 |
Eicker, SO; Floeth, FW; Galldiks, N; Herdmann, J; Langen, KJ; Steiger, HJ; Stoffels, G | 1 |
Gupta, V | 1 |
Flanagan, EP; Hunt, CH; Keegan, BM; Lowe, V; Mandrekar, J; O'Neill, BP; Pittock, SJ | 1 |
Ayrignac, X; Mariano-Goulart, D; Orgeval, J | 1 |
Flanagan, EP; Keegan, BM | 1 |
Benavides, DR; Hardy, SJ; Pardo, CA; Probasco, JC; Thakur, KT | 1 |
Alassiri, AH; Alharthi, A; Altinyay, ME; Syed, GM | 1 |
Endo, N; Kanazawa, M; Katsumi, K; Nishizawa, M; Wakasugi, N; Yajima, R | 1 |
Irioka, T; Mizusawa, H; Ota, K; Saito, K; Tsunemi, T; Watanabe, M; Yamanami, F | 1 |
Bing, Z; Chamroonrat, W; Cheng, G; Huang, S; Zhuang, H | 1 |
Sakushima, K; Sasaki, H; Shiga, T; Terae, S; Tsuji-Akimoto, S; Yabe, I; Yashima-Yamada, M | 1 |
Kataoka, H; Matsunaga, N; Seki, N; Suga, K; Taguchi, T; Yasuhiko, K | 1 |
Eicker, S; Floeth, FW; Galldiks, N; Herdmann, J; Langen, KJ; Rhee, S; Steiger, HJ; Stoffels, G | 1 |
Csere, T; Esik, O; Lengyel, E; Lengyel, Z; Nemeskéri, C; Repa, I; Sáfrány, G; Stefanits, K; Trón, L; Vönöczky, K | 1 |
Csornai, M; Esik, O; Lengyel, Z; Lesznyák, J; Majtényi, K; Pisch, J; Rékó, G; Trón, L | 1 |
Bajzik, G; Csere, T; Esik, O; Lengyel, E; Lengyel, Z; Olajos, J; Sáfrány, G; Stefanits, K; Szakáll, S; Trón, L; Vönöczky, K | 1 |
Alavi, A; Chamroonrat, W; El-Haddad, G; Posteraro, A; Zhuang, H | 1 |
2 review(s) available for fluorodeoxyglucose f18 and Spinal Cord Diseases
Article | Year |
---|---|
Clinical value of 2-deoxy-[18F]fluoro-D-glucose positron emission tomography in patients with cervical spondylotic myelopathy.
Topics: Cervical Vertebrae; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Spinal Cord Diseases; Spondylosis | 2013 |
A review on radiogenic Lhermitte's sign.
Topics: Butanols; Fluorodeoxyglucose F18; Humans; Methionine; Radiation Injuries; Radiotherapy; Spinal Cord; Spinal Cord Diseases | 2003 |
18 other study(ies) available for fluorodeoxyglucose f18 and Spinal Cord Diseases
Article | Year |
---|---|
Dual Time-Point 18F-FDG PET/CT in Spinal Sarcoidosis: A Single Institution Case Series.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Spinal Cord Diseases; Spinal Diseases | 2019 |
Clinicoradiological dissociation in sarcoid myelopathy.
Topics: Aged; Biopsy; Brain; Central Nervous System Diseases; Eye Pain; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Hypesthesia; Lymph Nodes; Lymphadenopathy; Magnetic Resonance Imaging; Male; Mediastinum; Middle Aged; Paresthesia; Peripheral Nervous System Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Spinal Cord; Spinal Cord Diseases | 2020 |
FDG PET/CT in Disseminated Intracranial and Intramedullary Spinal Cord Tuberculomas.
Topics: Brain; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Spinal Cord Diseases; Tuberculoma | 2021 |
Positron emission tomography in spinal cord disease.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Spinal Cord; Spinal Cord Diseases | 2013 |
[(18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Spinal Cord; Spinal Cord Diseases; Young Adult | 2013 |
Sensitivity of [18F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Spinal Cord; Spinal Cord Diseases | 2014 |
In reply--Sensitivity of [18F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Spinal Cord; Spinal Cord Diseases | 2014 |
A longitudinally extensive myelopathy in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antigens, CD19; Brain; Female; Flow Cytometry; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Radionuclide Imaging; Spinal Cord; Spinal Cord Diseases | 2015 |
18F-FDG Hypermetabolism in Spinal Cord Schistosomiasis.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Schistosomiasis; Spinal Cord Diseases; Tomography, X-Ray Computed; Young Adult | 2016 |
[A Patient with Cervical Spondylotic Myelopathy with 18F-FDG Uptake on Positron Emission Tomography/Computed Tomography].
Topics: Cervical Vertebrae; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Cord Diseases; Tomography, X-Ray Computed | 2016 |
18F-FDG PET successfully detects spinal cord sarcoidosis.
Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Spinal Cord Diseases | 2009 |
Elevated FDG activity in the spinal cord and the sciatic nerves due to neuropathy.
Topics: Aged; Biopsy; Fluorodeoxyglucose F18; Humans; Male; Radionuclide Imaging; Radiopharmaceuticals; Sciatic Neuropathy; Spinal Cord; Spinal Cord Diseases | 2009 |
FDG-PET SUV can distinguish between spinal sarcoidosis and myelopathy with canal stenosis.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Spinal Cord Compression; Spinal Cord Diseases; Spondylosis | 2011 |
F-18 FDG PET/CT findings in a case of spinal cord sarcoidosis.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Sarcoidosis; Spinal Cord Diseases; Tomography, X-Ray Computed | 2011 |
Prognostic value of 18F-FDG PET in monosegmental stenosis and myelopathy of the cervical spinal cord.
Topics: Aged; Aged, 80 and over; Cervical Vertebrae; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nervous System Diseases; Orthopedic Procedures; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Software; Spinal Cord Compression; Spinal Cord Diseases; Spinal Stenosis; Treatment Outcome | 2011 |
Autopsy verifies demyelination and lack of vascular damage in partially reversible radiation myelopathy.
Topics: Adult; Autopsy; Blood Vessels; Cervical Vertebrae; Demyelinating Diseases; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Medulla Oblongata; Meningitis; Methionine; Nerve Degeneration; Neurons; Oxygen Radioisotopes; Paraplegia; Radiation Injuries; Radiography; Radiotherapy; Spinal Cord; Spinal Cord Diseases; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
Increased metabolic activity in the spinal cord of patients with long-standing Lhermitte's sign.
Topics: Adult; Female; Fibroblasts; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Magnetic Resonance Imaging; Male; Methionine; Nasopharyngeal Neoplasms; Radiation Injuries; Radiation Tolerance; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Spinal Cord; Spinal Cord Diseases; Time Factors; Tomography, Emission-Computed | 2003 |
Radiation myelopathy visualized as increased FDG uptake on positron emission tomography.
Topics: Adult; Female; Fibromatosis, Aggressive; Fluorodeoxyglucose F18; Humans; Paresthesia; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Spinal Cord; Spinal Cord Diseases; Spinal Neoplasms; Thoracic Vertebrae | 2005 |